Oncocyte approves salary increases for CEO, interim CFO, and CSO effective May 20, 2024

Insight Molecular Diagnostics Inc.

CEO Joshua Riggs' base salary increased from $360,000 to $400,000.
Interim CFO/Principal Accounting Officer James Liu's salary raised from $200,000 to $207,000.
Chief Science Officer Ekkehard Schütz's salary rose from $351,525 to $378,025.

item 5.02

Insight Molecular Diagnostics Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-022193

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.